28
Oct
2025

IBSA

Exhibitor at CPHI Frankfurt 2025 stand 3.1F68, Finished Dosage Formulations
About Us

IBSA is a privately-owned pharmaceutical company, founded in Lugano in 1945. Thanks to a consolidated expansion strategy, IBSA is present with its products in 5 continents and in over 90 countries, including Europe, China and United States.  Overall, the Group employs 2,388 collaborators, spread among the various offices and production sites of its 20 subsidiaries in Europe, China and United States, while 160 people work in Research and Development laboratories. 
The IBSA Group currently holds 90 patent families, and several others in the pipeline.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2019
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1F68, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • VITAMIN D3 2000 UI - Orodispersible film

    Product VITAMIN D3 2000 UI - Orodispersible film

    DOSAGE FORM
    Oral film ➡ a very simple and practical form of taking the supplement
    - no water for assumption
    - it dissolves in a few seconds on the tongue
    - suitable to be taken at any time and in any condition, even by people with
    difficulty in swallowing, bedridden person or in co...
  • IALURIL PREFILL

    Product IALURIL PREFILL

    Ialuril® Prefill is indicated to re-establish the glycosaminoglycan layers (GAGs) ofthe urothelial vesical tissue in cases their loss can cause frequent and recurringproblems (such as, for example, cystitis of varying etiology).Ialuril® Prefill is also indicated in the cases where the loss of the glycosami...
  • SINOGEL

    Product SINOGEL

    Treatment of pain or reduced mobility due to degenerative affections (arthrosis),post-traumatic affections and tendinopathies associated with joint disability.
  • SINOVIAL HL

    Product SINOVIAL HL

    Pain or reduced mobility due to degenerative diseases (arthrosis), post-traumaticdiseases and tendinopathy associated with joint disabilities.